Pharmafile Logo
Pharmafocus logo
Advanced Search

roxadustat

Showing 2 posts of 2 posts found.

AstraZeneca’s roxadustat boosts haemoglobin levels in two Phase 3 trials

November 8, 2019
Medical Communications, Research and Development AstraZeneca, pharma, roxadustat

AstraZeneca’s hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) roxadustat has made a strong showing in the treatment of deficient haemoglobin (Hb) …

News

Astellas’ chronic kidney drug shows superiority at Phase 3

September 20, 2018
Research and Development Astellas, chronic kidney disease, pharma, roxadustat

Astellas has revealed new Phase 3 data for roxadustat in the treatment of chronic kidney disease (CKD) in patients with …

News
The Gateway to Local Adoption Series

Latest content

Equity starts with listening: putting community voices at the centre of access

September 21, 2026

Global coalition calls for stronger government action on COPD

September 18, 2026

Global health researchers call for more equitable partnerships

September 17, 2026

Liverpool launches £20m lab for infectious disease drug discovery

September 16, 2026

Circle Health Group expands into UK laboratory operations

September 15, 2026